Dissertation > Excellent graduate degree dissertation topics show

Gallic Acid Inhibited Neuroblastoma and Protected Testicular Sertoli Cytoskeletal Proteins Induced by Cyclophosphamide in Experimental Research

Author: HeWenFei
Tutor: HeDaWei
School: Chongqing Medical University
Course: Pediatrics
Keywords: Tumor Model Human Neuroblastoma Gallic acid Cyclophosphamide Vimentin
CLC: R739.4
Type: Master's thesis
Year: 2011
Downloads: 29
Quote: 0
Read: Download Dissertation

Abstract


Objective To investigate the feasibility of human neuroblastoma xenograft model in C57BL/6j mice. To study inhibitory effects of proliferative effect of Gallic acid (GA) on human neuroblastoma xenograft model, as well as the synergistic effect of cyclophosphamide (CP) chemotherapy, and to discuss that GA protected testicular cytoskeleton protein vimentin induced by CP.Methods 3day,7day,3week,4week,5week,6week and 7week age C57BL/6j and 6week age BALB/C nude mice were subcutaneously inoculated 1×107cell/ml huaman neuroblastoma SK-N-SH cells which were logarithmic phase, respectively. The tumor generation rate, relative tumor volume (RTV), relative growth rate (K), relative doubling time (Td), survival time and pathology were tested. The 3-week-old immunocompetent C57BL/6 mice were transplanted with SK-N-SH cells, distribution of randomized block design, 20 of each, the control groups:①PBS group, 0.5ml per bearing tumor mouse, intraperitoneally (i.p), as a negative control;②normal control group (NC), as the reproductivity of mice;③CP group, 75mg/kg per bearing tumor mouse, i.p, twice a week, total two weeks, as a positive control. Experimental groups:①GA group, administered gallic acid 250mg/kg i.p per bearing tumor mouse, every other day, continuous two weeks;②CP+GA group, GA and CP independent administration, dose and time with the above. All drugs are administrated at 9:00. Monitoring the relative tumor volume growth curves (RTV), body weight weekly, and measureing relative tumor volume growth rate. Tumor cell proliferation was detected by bromouracil deoxyriboside labeling (BrdU). To compare the absolute weight and the relative organ index of the testis, epididymis and seminal vescle. Immunohistochemistry, reverse transcriptase polymerase chain reaction (RT-PCR) and western blotting (WB) were used to detect testicular cytoskeleton protein vimentin mRNA expression and protein distribution.Results①The continuing tumor generation rate of C57BL/6j mice and BALB / C nude mice was 100% (10/10) in 3day, 100% (10/10) in 7day, 90% (9/10) in 3week and 70% (7/10) in 4week, 60%(6/10) in 5week, 0% (0/10) in 6week, 0% (0/10) in 7week and 100% (10/10) in 6week, respectively. There were no difference in RTV, K, Td, and survival time (P>0.05), compared to 3week C57BL/6j mice and BALB/C nude mice.②After administration of the 2nd-5th week, compareing each group RTV, GA+CP group<CP group<GA Group<PBS group, there were significant differences (P<0.01). After the administration of the 2nd week, GA group, CP group, GA + CP group of T/C (%) were: 74.83%, 33.11%, 10.98%, a significant difference (P<0.01). After the administration 5w, GA group, CP group, GA + CP group of T/C (%) were: 35.46%, 1.16%, 0, a significant difference (P<0.01). It was reallized that GA inhibited human neuroblastoma xenografts, and the synergistic effect of CP chemotherpy.③After administration of the 2nd week, the tumor cell proliferation index (LI) in the tumor tissues of mice treated with PBS-treated, GA-treated, CP-treated, and CP plus GA-treated groups were 0.23±0.08, 0.12±0.02, 0.11±0.02, 0.04±0.01, respectively. Compared with the PBS group was significant difference (P<0.01). The LI of the mice treated with CP combined with GA was significantly smaller than that the CP or GA group (P<0.01).④After administration of the 2nd week, PBS group body mass, testis, epididymis and seminal vesicle absolute weight lower than NC group (P<0.01), organ index was no significant difference (P>0.05). CP Group testis, epididymis, seminal vesicle organ index decreased compared with NC group (P<0.01), GA + CP group of organ index is higher than CP group (P<0.05), it realized that CP induced the damage of testis, epididymis, seminal vesicle in mice, but GA aginsted its toxicity. After the administration the 7th week, organ index of each group no significant difference (P>0.05), this showed that there may have a role in mice compensatory growth after CP chemotherapy.⑤After administration of the 2nd and 7th week, Immunohistochemistry showed that the distribution and expression of testicular cytoskeletal protein vimentin were similarly in GA group, GA+CP group and PBS group. CP group caused testicular cytoskeletal protein vimentin to collapse, which was disrupted and decreased the expression in the basement membrrane. After the administration of the 2nd week, GA group and the GA + CP group of testicular cytoskeletal protein vimentin mRNA and protein expression were increased, there was significant difference (P<0.01) compared with CP group. After the administration the 7th week, GA group and the GA + CP group of testicular cytoskeletal protein vimentin mRNA and protein expression increased, there were significant differences (P<0.05) compared with CP group, it showed that GA may against the effect of testicular cytoskeletal protein vimentin induced by CP.Conclusions①Human neuroblastoma xenograft model were successfully established the in immunecopetent C57BL/6j mice, as well as the most appropriate vaccination in 3 week age.②Gallic acid can inhibit tumor proliferation and synergism CP anti-tumor growth in human neuroblastoma xenograft.③GA may against the testis, epididymis and seminal vesicle toxicity induced by CP, and maintain normal distribution and expression of testicular cytoskeletal protein vimentin in vivo.

Related Dissertations

  1. Study of Sepia Ink-Astragalus Preparation for Relieving Damage Caused by Chemotherapy,R285.5
  2. The Experimental Study of Antiangiogenic and Induction of Apoptosis by Maximum Tolerated Dose Combined with Low-dose Cyclophosphamide in Breast Cancer,R737.9
  3. The Investigation of Vimentin Exons and Promoter Regions in Age-related Cortical Cataract,R776.1
  4. The Effects of Cytoskeleton Destruction Impacts on the Secretion and Matrix Metabolism of Rabbit Cartilage Cells in Vitro,R684.3
  5. Gallic Acid Production Wastewater and Waste Residue Treatment and Utilization,X703
  6. Study on Light Fastness Finishing of Natural Plant Colorant by Natural Antioxidants,TS195.1
  7. Pharmacokinetic Study of Qingbingkang in Chickens under the Condition of Immunity-inhibition,S858.31
  8. The meat pod Caesalpinia (Caesalpinia digyna) industrialization and Caesalpinia (Caesalpinia Linn.) Plants,S567.239
  9. Study of Effects of bFGF on the Recovery of the Spermatogenic Damage Induced by Cyclophosphamide in Mice,R73-3
  10. Expression and Clinical Significance of Vimentin, MMP-7 in Renal Cell Carcinoma,R737.11
  11. Leflunomide Vs. Cyclophosphamide in the Treatment of Lupus Nephritis: a Mata-analysis,R593.242
  12. The Protective Effects and Pathogensis of Mycophenolate Mofetil (MMF) on Diabetes in NOD Mice,R587.1
  13. Efefects of Glehnia Littora-lis Fr. Schmidt Ex Miq. on the Subset of T Lymphoycte of Cyclophosphamide Treated Mice,R285.5
  14. The Effect of Fas/FasL Pathway on Pbde-47-induced Apoptosis in SH-SY5Y Cells,R114
  15. Preliminary Study of TGF-β1 Expression and Epithelial-mesenchymal Transition in Human Lung Squamous-cell Carcinoma,R734.2
  16. Stdudy on Antioxidant Activities of Crude Water-soluble Polysaccharides from Hedysarum Polybotrys Hand.-Mazz.,R285.5
  17. Study on Preparation Process Preparation Procedure and Quality Standard of Xiaoer Zhixieling Effervescent Granules,R286
  18. Process Optimization and Dynamics Research of Synthesize Alkyl Gallate with Microwave Radiation,O621.3
  19. Attenuation of Cyclophosphamide Induced Immunosupression by Vitamin E in Laying Hens,S831.5
  20. The Observation of Effect and Analysis of Neoadjuvant Chemotherapy on Breast Cancer,R737.9
  21. Therapeutic Effects of Bone Marrow Transplantation on Injured Ovary Induced by Chemotherapy in Mice,R730.5

CLC: > Medicine, health > Oncology > Nervous system tumors
© 2012 www.DissertationTopic.Net  Mobile